Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03052231 · ClinicalTrials.gov registry record · NA
Interactive Mobile Health Information to Enhance Patient Care at a Cystic Fibrosis Center
A NA study, sponsored by Landon Pediatric Foundation.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT03052231 is a NA study that has completed, run by Landon Pediatric Foundation. The registered enrollment target is 80 participants.
The verdict
NCT03052231, a NA study, has completed, sponsored by Landon Pediatric Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
Real-world adherence to inhaled and oral therapies for cystic fibrosis (CF) patients remains discouragingly low, ranging between 31-53% for inhaled antibiotics and 41-72% for hypertonic saline. Programs to enhance adherence, including comprehensive behavioral interventions with adolescents, have met with mixed success. Advances in therapy, treatment delivery systems, and data capture technology offer the potential for enhancing adherence by providing immediate and more frequent feedback to the patient regarding his or her fidelity to the prescribed treatment regimen. The investigators propose to evaluate a systematic yet technically simple approach to linking treatment and feedback components to enhance adherence in a real-work CF clinic setting that treats a significant minority patient population. This is the first trial assessing the impact of a collaborative active intervention program of a multi disciplinary team in improving adherence to specific chronic medications and improving clinical outcomes in CF patients. The PI has implemented the texting service (Caremessage.org) with COPD and diabetes patients. The content will be modified to provide both English and Spanish language content relevant to these participants and their standard treatment protocols.
Interventions
- DEVICE caremessage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2016-03 |
| Est. Completion | 2017-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03052231
The ClinicalTrials.gov registry entry for NCT03052231 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Landon Pediatric Foundation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which caremessage is the first listed.
NCT03052231 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03052231 about?
NCT03052231 is a clinical study titled "Interactive Mobile Health Information to Enhance Patient Care at a Cystic Fibrosis Center". Real-world adherence to inhaled and oral therapies for cystic fibrosis (CF) patients remains discouragingly low, ranging between 31-53% for inhaled antibiotics and 41-72% for hypertonic saline. Programs to enhance adherence, including comprehensive behavioral interventions with adolescents, have met...
What is the current status of trial NCT03052231?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2016-03. Estimated completion is 2017-02.
What interventions are being tested in trial NCT03052231?
The interventions under investigation include: caremessage (DEVICE).
Who is sponsoring clinical trial NCT03052231?
This trial is sponsored by Landon Pediatric Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.